Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Reexamination Certificate
2008-07-22
2008-07-22
Yaen, Christopher (Department: 1643)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
C530S402000
Reexamination Certificate
active
07402660
ABSTRACT:
To gain a better understanding of tumor angiogenesis, new techniques for isolating endothelial cells (ECs) and evaluating gene expression patterns were developed. When transcripts from ECs derived from normal and malignant colorectal tissues were compared with transcripts from non-endothelial cells, over 170 genes predominantly expressed in the endothelium were identified. Comparison between normal- and tumor-derived endothelium revealed 79 differentially expressed genes, including 46 that were specifically elevated in tumor-associated endothelium. Experiments with representative genes from this group demonstrated that most were similarly expressed in the endothelium of primary lung, breast, brain, and pancreatic cancers as well as in metastatic lesions of the liver. These results demonstrate that neoplastic and normal endothelium in humans are distinct at the molecular level, and have significant implications for the development of anti-angiogenic therapies in the future.
REFERENCES:
patent: 5587458 (1996-12-01), King et al.
patent: 5644034 (1997-07-01), Rathjen et al.
patent: 6130068 (2000-10-01), Spriggs et al.
patent: 6174689 (2001-01-01), Spriggs et al.
patent: 6187909 (2001-02-01), Spriggs et al.
patent: 6667391 (2003-12-01), Drmanac et al.
patent: 1074617 (2001-02-01), None
patent: 1108790 (2001-06-01), None
patent: 4166095 (1992-06-01), None
patent: WO 84.11923 (1994-05-01), None
patent: WO 98/14576 (1998-04-01), None
patent: WO 99/21997 (1999-05-01), None
patent: WO 00/58473 (2000-10-01), None
patent: WO 00/77037 (2000-12-01), None
patent: WO 01/14420 (2001-03-01), None
patent: WO 01/17559 (2001-03-01), None
patent: WO 01/18044 (2001-03-01), None
patent: WO 01/18542 (2001-03-01), None
patent: WO 01/19988 (2001-03-01), None
patent: WO 01/46697 (2001-06-01), None
patent: WO 01/52616 (2001-07-01), None
patent: WO 01/53312 (2001-07-01), None
patent: WO 01/53500 (2001-07-01), None
patent: WO 01/57182 (2001-08-01), None
patent: WO 01/68848 (2001-09-01), None
patent: WO 01/71042 (2001-09-01), None
patent: WO 01/75067 (2001-10-01), None
patent: WO 01/77289 (2001-10-01), None
patent: WO 01/90304 (2001-11-01), None
patent: WO 01/92523 (2001-12-01), None
patent: WO 01/94629 (2001-12-01), None
patent: WO 02/10217 (2002-02-01), None
patent: WO 02/10767 (2002-02-01), None
patent: WO 02/22660 (2002-03-01), None
patent: WO 01/57272 (2002-06-01), None
patent: WO 01/57275 (2002-06-01), None
patent: WO 01/57276 (2002-06-01), None
patent: WO 01/57277 (2002-06-01), None
Jansen, M et al, 1995, Pediatric Res, 37 (6): 681-686.
Alberts et al. (Molecular Biology of the Cell, 3rd edition, 1994, p. 465.
Shantz and Pegg (Int J of Biochem and Cell Biol., 1999, vol. 31, pp. 107-122).
McClean and Hill (Eur J of Cancer, 1993, vol. 29A, pp. 2243-2248).
Fu et al (EMBO Journal, 1996, vol. 15, pp. 4392-4401).
Yokota, J et al (Oncogene, 1988,vol. 3, pp. 471-475).
Rudikoff et al (Proc Natl Acad Sci USA 1982 vol. 79 p. 1979.
Panka et al (Proc Natl Acad Sci USA vol. 85 3080-3084).
Amit et al Science vol. 233 747-753 1986.
Harlow et al. , Antibodies, A Laboratory Manual, Chapter 5, 1988.
Rettig, et al. “Identification Of Endosialin, A Cell Surface Glycoprotein Of Vascular Endothelial Cells In Human Cancer” Proc. Natl. Acad. Sci., vol. 89, pp. 10832-10836, Nov. 1992.
Christian, et al. “Molecular Cloning and Characterization of Endosialin, A C-type Lectin-Like Cell Surface Receptor of Tumor Endothelium”, the Journal of Biological Chemistry, vol. 276, No. 10 Mar. 9, 2001, 7408-7414.
Carninci, P. “High Efficiency full-length cDNA cloning,” Meth. Enzymol. (1999), 19-44, 303.
Gygi, Steven P. et al., “Correlation between Protein and mRNA Abundance in Yeast,”Molecular and Cellular Biology, (Mar. 1999), pp. 1720-1730, vol. 19, No. 3.
V. De Waard et al., “Serial analysis of gene expression to assess the endothelial cell response to an atherogenic stimulus”, Gene, vol. 226, No. 1, Jan. 8, 1999, pp. 1-8.
V.E. Velculescu et al., “Serial analysis of gene expression”, Science, vol. 270, No. 5235, Oct. 20, 1995, pp. 484-487.
A. Lal et al, “A pubic database fo gene expression in human cancers”, Cancer Research, vol. 59, No. 21, p. 5403-7, 1999.
B. St. Croix, “Genes expressedi n human tumor endothelium”, Science, vol. 289, No. 5482, Aug. 18, 2000, pp. 1197-1292.
Kinzler Kenneth W.
St. Croix Brad
Vogelstein Bert
Banner & Witcoff , Ltd.
The Johns Hopkins University
Yaen Christopher
LandOfFree
Endothelial cell expression patterns does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Endothelial cell expression patterns, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Endothelial cell expression patterns will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2813047